admin

Goodbye to face masks? It depends…

Xavier Sáez Llorens With the Omicron wave over, 75% of the population over 5 years of age vaccinated with a double schedule (more than 85% with 1 dose), 50% of adults with a booster, nearly 60% of inhabitants with partial immunity conferred by natural infection (estimated seroprevalence), availability of effective antivirals for the most vulnerable groups and a vast knowledge of society about personal protection measures, the obligation

Goodbye to face masks? It depends… Read More »

The omicron variant urges a change in pandemic strategy and a focus on the most vulnerable.

Dr. Javier Cotelo's position on the new pandemic scenario caused by the Omicron variant in Spain advocates for innovative modifications in epidemiological surveillance and diagnosis, as well as in healthcare organization, focusing all actions on vulnerable populations, according to the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). Dr. María del Mar Tomás Carmona,

The omicron variant urges a change in pandemic strategy, focusing it on the most vulnerable. Read More »

Genetic mutation for severe COVID-19 protects against HIV infection

By Nina Cosdón. A significant genetic risk factor for COVID-19, inherited from Neanderthals, significantly reduces the risk of contracting HIV. The severity of COVID-19 has proven mysterious, as some people experience severe or fatal illness, while others are virtually asymptomatic. In addition to advanced age and underlying medical conditions...

Genetic mutation for severe COVID-19 protects against HIV infection Read More »

Ravidasvir plus sofosbuvir is safe and effective for the treatment of HCV

CROI 2022 – By Pavankumar Kamat. Ravidasvir plus sofosbuvir demonstrated favorable safety and efficacy and was well tolerated in patients with hepatitis C virus (HCV) infection, including difficult-to-treat populations. Why is this important? There is an unmet need for inexpensive, direct-acting antivirals for the treatment of HCV infection.

Ravidasvir plus sofosbuvir is safe and effective for the treatment of HCV. Read More »